Patient presents with symptoms suggestive of a gastric mass, including [specific symptoms e.g., dyspepsia, early satiety, abdominal pain, weight loss, nausea, vomiting, melena, hematemesis].  Physical examination reveals [findings e.g., palpable abdominal mass, tenderness, hepatomegaly, lymphadenopathy].  Differential diagnosis includes gastric cancer, gastric lymphoma, gastrointestinal stromal tumor (GIST), benign gastric polyps, and other less common gastric neoplasms.  Diagnostic workup includes esophagogastroduodenoscopy (EGD) with biopsy, which is the gold standard for diagnosis.  Imaging studies such as CT scan of the abdomen and pelvis, endoscopic ultrasound (EUS), and potentially PET scan may be performed for staging and further evaluation of the gastric mass.  Laboratory tests including complete blood count (CBC), comprehensive metabolic panel (CMP), and tumor markers (e.g., CEA, CA 19-9) may be obtained.  Preliminary assessment suggests a [description of mass e.g., size, location, appearance] gastric mass.  Further investigation is required to determine the definitive diagnosis, histological type, and extent of disease.  A multidisciplinary approach involving gastroenterology, oncology, surgery, and pathology is warranted for optimal management. Treatment options for gastric mass depend on the final diagnosis and stage, and may include surgical resection, chemotherapy, radiation therapy, targeted therapy, or palliative care.  Patient education regarding the diagnosis, treatment options, and potential complications is essential.  Follow-up appointments are scheduled for discussion of biopsy results, further imaging, and development of a comprehensive treatment plan.